(Q34313506)

1 August 2017

1 reference

title

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications (English)

1 reference

1 August 2017

0 references

Yao JK

1

1 reference

1 August 2017

Reddy RD

series ordinal

2

1 reference

1 August 2017

van Kammen DP

series ordinal

3

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

287-310

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200115040-00004

1 August 2017

exact match

0 references

cites work

31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200115040-00004

Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

21 January 2018

1 reference

12 December 2020

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

1 reference

12 December 2020

Fat consumption and schizophrenia.

1 reference

12 December 2020

Effect of dietary 2-mercaptoethanol on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F1 mice

1 reference

12 December 2020

Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance

1 reference

12 December 2020

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

12 December 2020

Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia

1 reference

12 December 2020

A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines

1 reference

12 December 2020

Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?

1 reference

12 December 2020

Antioxidant vitamins in malnourished Nigerian children.

1 reference

12 December 2020

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

12 December 2020

Dyskinesias and their treatment with essential fatty acids: a review

1 reference

12 December 2020

The influence of cholesterol on synaptic fluidity and dopamine uptake

1 reference

12 December 2020

Free radical pathology and antioxidant defense in schizophrenia: a review

1 reference

12 December 2020

[Schizophrenia and prostaglandins. Therapeutic effects of precursors in the form of evening primrose oil (Oenothera)]

1 reference

12 December 2020

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

1 reference

12 December 2020

Studies on the enzyme catalyzing the conversion of 3,4-dihydroxyphenylethylamine to norepinephrine

1 reference

12 December 2020

Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators

1 reference

12 December 2020

Aging and disease: extending functional life span

1 reference

12 December 2020

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

12 December 2020

The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects

1 reference

12 December 2020

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

12 December 2020

Regulation of gamma-aminobutyric acid/barbiturate receptor-gated chloride ion flux in brain vesicles by phospholipase A2: possible role of oxygen radicals

1 reference

12 December 2020

Schizophrenia; a new approach. II. Result of a year's research

1 reference

12 December 2020

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

1 reference

12 December 2020

Effects of the Antioxidant Butylated Hydroxytoluene (BHT) on Mortality in BALB/c Mice

1 reference

12 December 2020

Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices

1 reference

12 December 2020

Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia

1 reference

12 December 2020

Neurochemistry and neuroendocrinology of schizophrenia: a selective review

1 reference

12 December 2020

Psychological stress and lipoperoxidation in miscarriage.

1 reference

12 December 2020

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

12 December 2020

Determinants of antioxidant status in humans

1 reference

12 December 2020

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

12 December 2020

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

1 reference

12 December 2020

Vitamin E and neurologic function in man.

1 reference

12 December 2020

5-HT2 receptors, roles and regulation

1 reference

12 December 2020

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines

1 reference

12 December 2020

[Glutathione peroxidase activity in the blood in chronic schizophrenia]

1 reference

12 December 2020

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

12 December 2020

Reduced level of plasma antioxidant uric acid in schizophrenia.

1 reference

12 December 2020

Increased Superoxide Dismutase Activity in Aged Human Cerebrospinal Fluid and Rat Brain Determined by Electron Spin Resonance Spectrometry Using the Spin Trap Method

1 reference

12 December 2020

Long-term treatment effects of vitamin E for tardive dyskinesia

1 reference

12 December 2020

The physiologic, neurologic, and behavioral effects of caloric restriction related to aging, disease, and environmental factors

1 reference

12 December 2020

The antioxidant paradox

1 reference

12 December 2020

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

12 December 2020

Oxidative injury and potential use of antioxidants in schizophrenia

1 reference

12 December 2020

Electrophysiological correlates of peroxide damage in guinea pig hippocampus in vitro

1 reference

12 December 2020

A liquid chromatographic method for the simultaneous determination of alpha-tocopherol and tocopherolquinone in human red blood cells and other biological samples where tocopherol is easily oxidized during sample treatment

1 reference

12 December 2020

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

12 December 2020

Reactive oxygen species and the central nervous system

1 reference

12 December 2020

A comparison of antioxidant status and free radical peroxidation of plasma lipoproteins in healthy young persons from Naples and Bristol

1 reference

12 December 2020

Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients.

1 reference

12 December 2020

The role of glutamate in behavioral and neurotoxic effects of methamphetamine

1 reference

12 December 2020

Schizophrenia: a neuropathological perspective

1 reference

12 December 2020

Alterations of neutrophil oxidative burst by in vitro smoke exposure: implications for oral and systemic diseases

1 reference

12 December 2020

[Lipid peroxidation processes in patients with schizophrenia]

1 reference

12 December 2020

The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma

1 reference

12 December 2020

Oxidative damage and mitochondrial decay in aging

1 reference

12 December 2020

Dopamine neurotoxicity: inhibition of mitochondrial respiration

1 reference

12 December 2020

Requirement for superoxide in excitotoxic cell death.

1 reference

12 December 2020

Mitochondrial role in cell aging

1 reference

12 December 2020

Electron microscopic study on schizophrenia. Mechanism of pathological changes.

1 reference

12 December 2020

1 reference

12 December 2020

Role of hydroxyl radicals in the activation of human platelets

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study

1 reference

12 December 2020

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

12 December 2020

1 reference

12 December 2020

Erythrocyte and platelet levels of superoxide dismutases (1 and 2) and glutathione peroxidase in developmental child psychoses

1 reference

12 December 2020

Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus.

1 reference

12 December 2020

Reduced status of plasma total antioxidant capacity in schizophrenia.

1 reference

12 December 2020

Increased pentane and carbon disulfide in the breath of patients with schizophrenia

1 reference

12 December 2020

Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse

1 reference

12 December 2020

Ethanol-induced lipid peroxidation: potentiation by long-term alcohol feeding and attenuation by methionine

1 reference

12 December 2020

Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics.

1 reference

12 December 2020

[Indices of lipid free-radical oxidation and of antiradical protection of the brain--the neurochemical correlates of the development of the general adaptation syndrome]

1 reference

12 December 2020

Cigarette smoking and health: a radical view.

1 reference

12 December 2020

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

1 reference

12 December 2020

Treatment of tardive dyskinesia with vitamin E.

1 reference

12 December 2020

Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients

1 reference

12 December 2020

Oxidative stress and superoxide dismutase in schizophrenia

1 reference

12 December 2020

Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis

1 reference

12 December 2020

Vitamin E treatment of tardive dyskinesia

1 reference

12 December 2020

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1 reference

12 December 2020

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

12 December 2020

Human plasma glutathione peroxidase and symptom severity in schizophrenia

1 reference

12 December 2020

Impaired antioxidant defense at the onset of psychosis.

1 reference

12 December 2020

1 reference

12 December 2020

Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables

1 reference

12 December 2020

Superoxide dismutase activities in aging rat brain.

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia

1 reference

12 December 2020

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

1 reference

12 December 2020

[Morphology of the orbitofrontal cortex in persons schizophrenic psychotics. A Golgi and electron microscopy study]

1 reference

12 December 2020

The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism

1 reference

12 December 2020

Cellular and molecular effects of polyunsaturated fatty acids in brain ischemia and injury

1 reference

12 December 2020

Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography

1 reference

12 December 2020

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

1 reference

12 December 2020

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

1 reference

12 December 2020

Superoxide dismutase 1 and glutathione peroxidase levels in erythrocytes of adult schizophrenics

1 reference

12 December 2020

Use of smokeless tobacco and cigarettes--effects on plasma levels of antioxidant vitamins

1 reference

12 December 2020

Whither vitamin E and tardive dyskinesia?

1 reference

12 December 2020

Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan

1 reference

12 December 2020

Decreased serotonergic responsivity in platelets of drug-free patients with schizophrenia

1 reference

12 December 2020

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

12 December 2020

Transient Formation of Superoxide Radicals in Polyunsaturated Fatty Acid-Induced Brain Swelling

1 reference

12 December 2020

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

1 reference

12 December 2020

Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease

1 reference

12 December 2020

Erythrocyte membrane phospholipids in psychotic patients

1 reference

12 December 2020

Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia.

1 reference

12 December 2020

Effect of Ethoxyquin on the Longevity of C3H Mice

1 reference

12 December 2020

Polyunsaturated fatty acids, prostaglandins, and schizophrenia

1 reference

12 December 2020

Vitamin C status in chronic schizophrenia

1 reference

12 December 2020

Role of lipid peroxidation in the pathogenesis of the ethanol-induced fatty liver

1 reference

12 December 2020

Enzymatic/nonenzymatic sources of oxyradicals and regulation of antioxidant defenses.

1 reference

12 December 2020

Essential fatty acids in plasma phospholipids in schizophrenics

1 reference

12 December 2020

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1 reference

12 December 2020

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

1 reference

12 December 2020

Oxidative reactions and schizophrenia: a review-discussion

1 reference

12 December 2020

Vitamin E treatment of tardive dyskinesia

1 reference

12 December 2020

Superoxide dismutase activity in developing rat brain

1 reference

12 December 2020

Peroxidation induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid

1 reference

12 December 2020

Effect of thermal stress on glutathione metabolism in human erythrocytes.

1 reference

12 December 2020

Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.

1 reference

12 December 2020

Inhibition of free radical production or free radical scavenging protects from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons.

1 reference

12 December 2020

Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms.

1 reference

12 December 2020

Elevated plasma lipid peroxides at the onset of nonaffective psychosis

1 reference

12 December 2020

Glutamate receptor dysfunction and schizophrenia

1 reference

12 December 2020

Biological studies in schizophrenia

1 reference

12 December 2020

The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent

1 reference

12 December 2020

Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes

1 reference

12 December 2020

Prevalence of smoking among psychiatric outpatients

1 reference

12 December 2020

Free radical mechanisms in schizophrenia and tardive dyskinesia

1 reference

12 December 2020

Essential fatty acid supplementation in tardive dyskinesia

1 reference

12 December 2020

Analysis of platelet superoxide dismutase 1 in the development of childhood psychoses

1 reference

12 December 2020

Alpha-tocopherol in tardive dyskinesia

1 reference

12 December 2020

Schizophrenia as a membrane lipid disorder which is expressed throughout the body

1 reference

12 December 2020

Free-radical chemistry of cigarette smoke and its toxicological implications

1 reference

12 December 2020

Oxygen free radicals and brain dysfunction

1 reference

12 December 2020

Structural lesions of the brain in young schizophrenics.

1 reference

12 December 2020

Smoking and schizophrenia

1 reference

12 December 2020

Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia

1 reference

12 December 2020

Effects of neuroleptics on the lipid peroxidation and peroxide metabolism enzyme activities in various discrete areas of the rat brain.

1 reference

12 December 2020

10.2165/00023210-200115040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1025269086

0 references

1 reference